June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
The added value of undiluted vitreous biopsy samples processed by the Cellient® tissue processor (Hologic) in intermediate or posterior uveitis.
Author Affiliations & Notes
  • Joachim Van Calster
    Ophthalmology, University Hospitals Leuven, Leuven, Belgium
  • Rita Van Ginderdeuren
    Ophthalmology, University Hospitals Leuven, Leuven, Belgium
  • Footnotes
    Commercial Relationships Joachim Van Calster, Allergan (C), Allergan (R), Bausch&Lomb (F), Bayer (C), Bayer (R), DORC (C), DORC (R), MSD (C), Novartis (C), Novartis (F), Novartis (R); Rita Van Ginderdeuren, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3142. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joachim Van Calster, Rita Van Ginderdeuren; The added value of undiluted vitreous biopsy samples processed by the Cellient® tissue processor (Hologic) in intermediate or posterior uveitis.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3142.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: In this prospective study, the added value of undiluted vitreous biopsy samples in the diagnosis of intermediate and posterior uveitis was evaluated. Vitreous biopsies are difficult to handle because of the paucity of cells and the gelatinous structure of the vitreous. Histopathological analysis of the vitreous is useful in difficult uveitis cases to differentiate uveitis from lymphoma or infection and to define the type of cellular reaction.

Methods: 97 consecutive undiluted vitreous samples were isolated in patients with unsolved intermediate or posterior uveitis. A 1.5-2.5cc sample was taken through a single 23G port using the EVA vitrectomy platform (DORC) with a twin duty cycle high speed cutter. The samples were analysed with the Cellient® tissue processor (Hologic). This machine is a fully automated processor starting from a specified container with PreservCyt® (fixative fluid) with cells to paraffin. Routine histochemical and immunostainings were evaluated.

Results: In 94.8% of the cases, sufficient material was found to provide an added value in the diagnostic workup. In 34%, a Cytolyt® mucolytic wash was necessary to prevent clotting of the tubes in the Cellient® tissue processor due to the viscosity of the sample. In 7% the diagnosis was an acute inflammation (presence of granulocytes), in 42% chronic active inflammation (presence of T-lymphocytes), in 36% low-grade inflammation (presence of CD68 cells, with <5% T-lymphocytes); and in 9% a malignant process (lymphoma). In 5% no diagnosis was found. In the chronic active inflammation group 39% was a granulomatous inflammatory process.

Conclusions: This standardized protocol for sampling and handling undiluted vitreous biopsies gives a superior result in morphology, number of cells, and possibility of immuno-histochemical stainings. The diagnosis can be established or confirmed in 94.8% of cases.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.